Aegis Industries Announces ``Cells to Society'' Human Electromuscular Incapacitation (HEMI) R&D Program.CAMBRIDGE Cambridge, city, Canada Cambridge (kām`brĭj), city (1991 pop. 92,772), S Ont., Canada, on the Grand River, NW of Hamilton. It was formed in 1973 with the amalgamation of Galt, Hespeler, and Preston, all founded in the early 19th cent. , Mass. -- Aegis Industries, Inc, Office of Science and Technology, announces a broad "Cells to Society" R&D effort to support new advancements in Human Electro-muscular E`lec`tro-mus´cu`lar a. 1. (Physiol.) Pertaining to the reaction (contraction) of the muscles under electricity, or their sensibility to it. Incapacitation in·ca·pac·i·tate tr.v. in·ca·pac·i·tat·ed, in·ca·pac·i·tat·ing, in·ca·pac·i·tates 1. To deprive of strength or ability; disable. 2. To make legally ineligible; disqualify. (HEMI) technology. The privately funded effort involves academic, private sector, military and governmental participation and covers cellular mechanisms using in silico models, organismic or·gan·ism n. 1. An individual form of life, such as a plant, animal, bacterium, protist, or fungus; a body made up of organs, organelles, or other parts that work together to carry on the various processes of life. 2. responses to advanced waveforms, advanced hardware and software integration, new perspectives on HEMI training and an emphasis on human and civil rights. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Bruno D.V. Marino, Chief Science and Technology Officer who developed the Aegis program, "The 'Cells to Society' R&D effort was created to fill gaps and uncertainties in our knowledge of the fundamentals of HEMI and it's consequences, particularly the unintended ones." While there is clearly a national debate on many issues of stun device usage ranging from public safety to civil rights, the need for new technology approaches and basic health effects data are desperately needed but still lacking. "A comprehensive HEMI program is lacking and without one the industry cannot move forward," remarked Kenneth J. Stethem, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Aegis. Aegis products include HEMI-based, multi-sensory and other advanced Intermediate Force Options(R) as alternatives to lethal lethal /le·thal/ (le´th'l) fatal. le·thal adj. 1. Capable of causing death. 2. Of, relating to, or causing death. lethal deadly; fatal. force. A rigorous R&D program based on high quality, independent and peer reviewed publications will help expand the industry and enjoy wider public acceptance of the technology as well as identify its limitations. "The 'Cells to Society' program was developed to cross disciplinary boundaries linking knowledge from cellular mechanisms to efficacy and health effects to the implications of HEMI use-of-force across populations, culture, human rights and civil rights," Dr. Marino noted. R&D efforts are underway in related areas including safety testing of Aegis' initial product, the Mark 63 Multi-Sensory Device that will be available in early 2006. Aegis Industries, Inc. is the emerging market leader in the stun industry and specializes in the design and development of intermediate force options for the military, law enforcement, corrections, and the private security industry. You can learn more about Aegis Industries at www.aegispds.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion